M. Saruta

发表

Roles of top and first Ni-layers in the improvement of electrical property and surface morphology in Ni/Al/Ni/n-InP contacts

T. Okumura, S. Miyazaki, M. Saruta, 1997 .

Alanine-Serine-Cysteine Transporter 2 Inhibition Suppresses Prostate Cancer Cell Growth In Vitro

Motoshi Suzuki, M. Sumitomo, K. Zennami, 2022, Journal of clinical medicine.

Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer cells

Motoshi Suzuki, M. Sumitomo, N. Fukami, 2020, Prostate international.

Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.

K. Takahara, R. Shiroki, Shunsuke Tsuzuki, 2023, Cancer medicine.

Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study

K. Zennami, M. Ichino, R. Shiroki, 2023, Scientific reports.

Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.

K. Takahara, R. Shiroki, H. Azuma, 2023, Clinical genitourinary cancer.

Robot-assisted radical prostatectomy with the Hugo™ robot-assisted surgery system: A single-center initial experience in Japan.

K. Zennami, M. Ichino, R. Shiroki, 2024, Asian journal of endoscopic surgery.

Impact of an enhanced recovery protocol in frail patients after intracorporeal urinary diversion.

K. Zennami, M. Kusaka, R. Shiroki, 2024, BJU international.

Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.

R. Shiroki, K. Komura, T. Inamoto, 2024, Targeted oncology.